Box score
Mangrove Therapeutics Inc.
Reported $2.5M sold in a new Form D filed July 31, 2026 (Sacramento, California).
- Biggest raise
- $2.5M filed Jul 31, 2026
- League
- Bio & Health Biotechnology
- Based in
- Sacramento, California
- Season rank
- #489 of 1,121 in the Bio & Health League; #4149 of 10,745 overall (2026)
- Incorporated
- 2025
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-07-31 | New notice | $2.5M | $5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2111089.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Kindra Corp | Bio & Health | $2.6M |
| 2 | Long Bridge Medical, Inc. | Bio & Health | $2.5M |
| 3 | Zonaliz, Inc. rookie | Bio & Health | $2.5M |
| 4 | Hawthorne Health, Inc. rookie | Bio & Health | $2.5M |
| 5 | Sensible Care Inc. | Bio & Health | $2.3M |
| 6 | Rose Diagnostics Inc. | Bio & Health | $2.2M |